CLARUS THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Derivative Liabilities
CLARUS THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Derivative Liabilities of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2022-03-31
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-06-30 was $1.70M.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-03-31 was $11.20M.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in derivative liabilities for the quarter ending 2020-12-31 was -$13.03M.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in derivative liabilities for fiscal 2021 was $0.00.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in derivative liabilities for fiscal 2020 was -$66.34M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-31 | |||
| 2021-06-30 | $1.70M 10-Q · filed 2021-08-16 | $9.40M 10-Q · filed 2021-08-16 | -$127.00K derived: sum of 3 quarters · filed 2022-03-31 | |
| 2021-03-31 | $11.20M 10-Q · filed 2021-05-26 | -$1.83M derived: sum of 2 quarters · filed 2022-03-31 | ||
| 2020-12-31 | -$13.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$66.34M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$53.31M 10-Q · filed 2021-11-19 |